AI assistant
Arcadia Biosciences, Inc. — Director's Dealing 2016
Aug 22, 2016
35424_dirs_2016-08-22_e9c61717-5f74-486b-9524-a871983201d5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2016-08-18
Reporting Person: Lu Zhongjin (VP Product Development)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-08-18 | Stock Option (right to buy) | $2.14 | A | 50000 | Acquired | 2026-08-17 | Common Stock (50000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 17101 | Direct |
Footnotes
F1: Reflects the purchase of (i) 750 shares of the Issuer's common stock on 2/1/16 at a per share purchase price of $2.54, and (ii) 1,591 shares of the Issuer's common stock at a per share purchase price of $2.07, each pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan.
F2: The option vests as to 25% of the award on the first anniversary of the date of the award (or August 18, 2017) and the remaining 75% thereafter vests in 36 equal installments beginning August 31, 2017 and continuing on the last day of each of the next 35 months, with the last vesting to occur on July 31, 2020.